GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4 R(1)(a) and (c) GlaxoSmithKline plc (GSK) was advised on 7 November 2014 of the following increase in the notional allocation of GSK American Depositary Shares (ADSs) on 6 November 2014, at a price of $44.75 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:
Director/PDMR |
Number of ADSs |
Mrs D P Connelly |
1 |
Mr W C Louv |
24 |
Dr M M Slaoui |
17 |
Connected person |
Number of ADSs |
Dr K Slaoui (connected person of Dr M M Slaoui) |
16 |
V A Whyte
Company Secretary
7 November 2014